Geode Capital Management
LEGN icon

Geode Capital Management’s Legend Biotech LEGN Stock Holding History

Geode Capital Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.2M Buy
563,489
+13,438
+2% +$362K ﹤0.01% 2277
2026
Q1 		$9.87M Sell
550,051
-5,385
-1% -$103K ﹤0.01% 2387
2025
Q4 		$12M Buy
555,436
+15,394
+3% +$441K ﹤0.01% 2319
2025
Q3 		$17.5M Buy
540,042
+66,300
+14% +$2.45M ﹤0.01% 2066
2025
Q2 		$16.7M Sell
473,742
-49,049
-9% -$1.59M ﹤0.01% 2050
2025
Q1 		$17.6M Buy
522,791
+3,317
+0.6% +$119K ﹤0.01% 1967
2024
Q4 		$16.8M Buy
519,474
+24,610
+5% +$1.02M ﹤0.01% 2059
2024
Q3 		$23.9M Buy
494,864
+17,337
+4% +$923K ﹤0.01% 1886
2024
Q2 		$21M Buy
477,527
+14,920
+3% +$688K ﹤0.01% 1908
2024
Q1 		$25.8M Buy
462,607
+21,732
+5% +$1.31M ﹤0.01% 1769
2023
Q4 		$26.4M Buy
440,875
+79,673
+22% +$5.05M ﹤0.01% 1745
2023
Q3 		$24.1M Buy
361,202
+27,413
+8% +$1.9M ﹤0.01% 1702
2023
Q2 		$22.9M Buy
333,789
+11,821
+4% +$772K ﹤0.01% 1765
2023
Q1 		$15.4M Buy
321,968
+50,641
+19% +$2.48M ﹤0.01% 1969
2022
Q4 		$13.5M Buy
271,327
+11,385
+4% +$552K ﹤0.01% 2052
2022
Q3 		$10.6M Buy
259,942
+20,626
+9% +$968K ﹤0.01% 2207
2022
Q2 		$13.1M Buy
239,316
+9,775
+4% +$413K ﹤0.01% 2065
2022
Q1 		$8.29M Buy
229,541
+11,719
+5% +$463K ﹤0.01% 2471
2021
Q4 		$10.1M Buy
217,822
+202,053
+1,281% +$10.2M ﹤0.01% 2446
2021
Q3 		$797K Hold
15,769
– – ﹤0.01% 3807
2021
Q2 		$647K Sell
15,769
-1,430
-8% -$48.6K ﹤0.01% 3814
2021
Q1 		$499K Hold
17,199
– – ﹤0.01% 3811
2020
Q4 		$484K Buy
17,199
+5,783
+51% +$166K ﹤0.01% 3599
2020
Q3 		$352K Buy
11,416
+413
+4% +$13.9K ﹤0.01% 3541
2020
Q2 		$468K Buy
+11,003
New +$430K ﹤0.01% 3401

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Geode Capital Management's LEGN Position: Q2 2026 in Review

Geode Capital Management increased its Legend Biotech (LEGN) stake by 2.4% in Q2 2026, buying an estimated $362K and bringing the position to 563,489 shares worth $16.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2277.

Geode Capital Management first reported a position in LEGN in Q2 2020 and has held it in 25 quarters since. The position peaked at $26.4M in Q4 2023. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Geode Capital Management held 563,489 shares of Legend Biotech worth $16.2M as of Q2 2026.
  • Geode Capital Management bought 13,438 Legend Biotech shares in Q2 2026, an estimated $362K.
  • Legend Biotech made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #2277 holding.
  • Geode Capital Management first reported a position in Legend Biotech in Q2 2020 and has held it in 25 quarters since.
  • Geode Capital Management's Legend Biotech position peaked at $26.4M in Q4 2023.
  • 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.